Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Protein; Transport Protein”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Ended earlyNCT00637767
What this trial is testing

High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Southampton 25
Not applicableStudy completedNCT04145154
What this trial is testing

Plasma and Scarring of Diabetic Ulcers

Who this might be right for
Chronic Skin UlcerDiabetic FootPlasma Protein; Transport Protein
Universidad de Guanajuato 16
Testing effectiveness (Phase 2)WithdrawnNCT04022161
What this trial is testing

Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients

Who this might be right for
Cardiovascular DiseasesOxidative StressEndothelial Dysfunction
Massachusetts General Hospital
Testing effectiveness (Phase 2)Temporarily pausedNCT04505813
What this trial is testing

Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma
NexImmune Inc. 9
Early research (Phase 1)Study completedNCT02519452
What this trial is testing

Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 120
Early research (Phase 1)WithdrawnNCT03506802
What this trial is testing

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

Who this might be right for
HLA-A*0201 Positive Cells PresentNY-ESO-1 Positive Tumor Cells PresentRecurrent Plasma Cell Myeloma+1 more
Jonsson Comprehensive Cancer Center
Not applicableUnknownNCT01009723
What this trial is testing

Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers

Who this might be right for
Preterm Delivery
Esoterix Genetic Laboratories, LLC 2,000
Large-scale testing (Phase 3)Study completedNCT00001561
What this trial is testing

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Who this might be right for
Graft vs Host DiseaseMultiple Myeloma
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT04121260
What this trial is testing

Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 21
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Testing effectiveness (Phase 2)Ended earlyNCT03033316
What this trial is testing

A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Enceladus Pharmaceuticals BV 7
Testing effectiveness (Phase 2)Study completedNCT00499577
What this trial is testing

Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland Greenebaum Cancer Center 56
Not applicableStudy completedNCT06559709
What this trial is testing

A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant

Who this might be right for
Multiple Myeloma
Fred Hutchinson Cancer Center 26
Not applicableActive Not RecruitingNCT06328699
What this trial is testing

Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation

Who this might be right for
LymphomaMultiple Myeloma
Emory University 50
Testing effectiveness (Phase 2)Study completedNCT00001750
What this trial is testing

Comparing Treatments for Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 32
Not applicableNot Yet RecruitingNCT07721350
What this trial is testing

Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System

Who this might be right for
Multiple Myeloma or Amyloidosis
Hospices Civils de Lyon 100
Early research (Phase 1)Active Not RecruitingNCT00881920
What this trial is testing

Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL

Who this might be right for
LymphomaMyelomaLeukemia
Baylor College of Medicine 54
Not applicableStudy completedNCT05274763
What this trial is testing

Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant

Who this might be right for
LymphomaPlasma Cell Myeloma
Emory University 30
Early research (Phase 1)Temporarily pausedNCT07340853
What this trial is testing

CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Thomas Martin, MD 30
Next Page